Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bekasi Asri Pemula Tbk (BAPA) vs Dharma Polimetal Tbk. (DRMA)

Bekasi Asri Pemula TbkTrading
Dharma Polimetal Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bekasi Asri Pemula Tbk dan Dharma Polimetal Tbk.: Bekasi Asri Pemula Tbk diperdagangkan di Rp145 (kapitalisasi pasar 99,93 M, volume 24 jam 6,55 jt), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp985 (kapitalisasi pasar 4,64 T, volume 24 jam 531,1 rb). Perbedaan utamanya: Dharma Polimetal Tbk. jauh lebih besar — sekitar 46,4× kapitalisasi pasar Bekasi Asri Pemula Tbk, dan Bekasi Asri Pemula Tbk lebih aktif diperdagangkan (6,55 jt vs 531,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

BAPADRMA
Kapitalisasi Pasar
99,93 M4,64 T
Volume
6,55 jt531,1 rb
Lot
65,5 rb5,31 rb
Perputaran
969,81 jt523,32 jt
Harga Rata-rata
148,07985,35
Nilai Transaksi
969,81 jt523,32 jt
Harga Ekuilibrium Indikatif
145985
Volume Ekuilibrium Indikatif
880125

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BAPA
Lihat detail
DRMA
Lihat detail

Tentang Bekasi Asri Pemula Tbk

PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.

Selengkapnya di halaman BAPA

Tentang Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Selengkapnya di halaman DRMA